Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1267-1274

  Hua, Dong ^a   Shen, Li ^a,b   Xu, Lan ^a   Jiang, Zhi ^a   Zhou, Yinghui ^a   Yue, Aihuan ^a   Zou, Shitao ^a   Cheng, Zhihong ^a   Wu, Shiliang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Gastric cancer; Matrix metalloproteinase 2; Metastasis; Polypeptide N acetylgalactosaminyltransferase 2; Transforming growth factor 1

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE; POLYPEPTIDE 'N ACETYLGALACTOSAMINYLTRANSFERASE 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; METASTASIS; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; STOMACH CANCER;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; N-ACETYLGALACTOSAMINYLTRANSFERASES; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84869460432     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1130     Document Type: Article

References (32)

1. Brooks SA, Carter TM, Bennett EP, Clausen H and Mandel U: Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer. Acta Histochem 109: 273-284, 2007. (Pubitemid 46962083)
2. Zhang H, Meng F, Wu S, et al: Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling. Cancer Res 71: 4846-4856, 2011.
3. Christie DR, Shaikh FM, Lucas JA IV, Lucas JA III and Bellis SL: ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res 1: 3, 2008.
4. Meany DL and Chan DW: Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin Proteomics 8: 7, 2011.
5. Petretti T, Schulze B, Schlag PM and Kemmner W: Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta 1428: 209-218, 1999. (Pubitemid 29352268)
6. Chandrasekaran EV, Xue J, Piskorz C, et al: Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of alpha1,2-fucosyltransferase activities. J Cancer Res Clin Oncol 133: 599-611, 2007. (Pubitemid 47077051)
7. Shimizu F, Nakayama J, Ishizone S, et al: Usefulness of the real-time reverse transcription-polymerase chain reaction assay targeted to alpha1,4-N-acetylglucosaminyltransferase for the detection of gastric cancer. Lab Invest 83: 187-197, 2003. (Pubitemid 36255364)
8. Liu Z, Shen L, Xu L, Sun X, Zhou J and Wu S: Downregulation of β-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer. Mol Med Rep 4: 497-503, 2011.
9. Zlocowski N, Sendra VG, Lorenz V, et al: Catalytic and glycan-binding abilities of ppGalNAc-T2 are regulated by acetylation. Biochem Biophys Res Commun 410: 140-145, 2011.
10. Li X, Wang J, Li W, et al: Characterization of ppGalNAc-T18, a member of the vertebrate-specific Y subfamily of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferases. Glycobiology 22: 602-615, 2012.
11. Peng C, Togayachi A, Kwon YD, et al: Identification of a novel human UDP-GalNAc transferase with unique catalytic activity and expression profile. Biochem Biophys Res Commun 402: 680-686, 2010.
12. Mandel U, Hassan H, Therkildsen MH, et al: Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. Glycobiology 9: 43-52, 1999. (Pubitemid 29041603)
13. Gao Y, Tu YB, Guo Y, et al: PpGalNacT2 participating in vanadium-induced HL-60 cell differentiation. Mol Biol Rep 38: 1483-1489, 2011.
14. Liu C, Lin D, Xu L, Jiang Z, Zhou Y and Wu S: An anti-human ppGalNAcT-2 monoclonal antibody. Hybridoma 30: 549-554, 2011.
15. Liu J, Yang L, Jin M, Xu L and Wu S: regulation of the invasion and metastasis of human glioma cells by polypeptide N- acetylgalactosaminyltransferase 2. Mol Med Rep 4: 1299-1305, 2011.
16. Shen L, Liu Z, Tu Y, Xu L, Sun X and Wu S: Regulation of MMP-2 expression and activity by beta-1,3-N-acetylglucosaminyltransferase- 8 in AGS gastric cancer cells. Mol Biol Rep 38: 1541-1550, 2011.
17. Milac AL, Buchete NV, Fritz TA, Hummer G and Tabak LA: Substrate-induced conformational changes and dynamics of UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase-2. J Mol Biol 373: 439-451, 2007. (Pubitemid 47445582)
18. Ten Hagen KG, Fritz TA and Tabak LA: All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13: 1R-16R, 2003. (Pubitemid 36372510)
19. Wei M, Wang Z, Yao H, et al: P27(Kip1), regulated by glycogen synthase kinase-3beta, results in HMBA-induced differentiation of human gastric cancer cells. BMC Cancer 11: 109, 2011.
20. Zeng Y, Yang Z, Xu JG, Yang MS, Zeng ZX and You C: Differentially expressed genes from the glioblastoma cell line SHG-44 treated with all-trans retinoic acid in vitro. J Clin Neurosci 16: 285-294, 2009.
21. Qiu H, Guo XH, Mo JH, Jin MF, Wu SL and Chen HL: Expressions of polypeptide: N-acetylgalactosaminyltransferase in leukemia cell lines during 1,25-dihydroxyvitamin D3 induced differentiation. Glycoconj J 23: 575-584, 2006. (Pubitemid 44477399)
22. Jia HP, Look DC, Shi L, et al: ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 79: 14614-14621, 2005. (Pubitemid 41636260)
23. Xu S, Mou H, Lu G, et al: Gene expression profile differences in high and low metastatic human ovarian cancer cell lines by gene chip. Chin Med J (Engl) 115: 36-41, 2002. (Pubitemid 34130432)
24. Langley RR and Fidler IJ: Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28: 297-321, 2007. (Pubitemid 46984829)
25. Fidler IJ: The organ microenvironment and cancer metastasis. Differentiation 70: 498-505, 2002.
26. Li Y, Li B, Xiang CP, Zhang Y, Li YY and Wu XL: Characterization of gastric cancer models from different cell lines orthotopically constructed using improved implantation techniques. World J Gastroenterol 18: 136-143, 2012.
27. Li HZ, Wang Y, Gao Y, et al: Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 6: 917-928, 2008.
28. Li HZ, Gao Y, Zhao XL, et al: Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 7: 832-840, 2009.
29. Gao M, Zhang JH, Zhou FX, et al: Angelica sinensis suppresses human lung adenocarcinoma A549 cell metastasis by regulating MMPs/TIMPs and TGF-β1. Oncol Rep 27: 585-593, 2012.
30. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994. (Pubitemid 24216953)
31. Zucker S, Drews M, Conner C, et al: Tissue inhibitor of metalloproteinase- 2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273: 1216-1222, 1998. (Pubitemid 28049224)
32. Taipale J, Miyazono K, Heldin CH and Keski-Oja J: Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 124: 171-181, 1994. (Pubitemid 24054619)